News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DRUG market cap is 241.12M. The company's latest EPS is CAD -0.4009 and P/E is -85.78.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.45M | -814k | 228k | -792k | -1.62M |
| Net Income | -1.68M | -574k | 230k | -774k | 50k |
| Year End September 29 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -7.68M | -13.31M | -6.56M | -2.82M |
| Net Income | -8.65M | -14.97M | -7.37M | -2.8M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | ||
| Total Assets | 6.89M | 6.53M | 6.28M | 6.11M | 58.4M |
| Total Liabilities | 854k | 846k | 178k | 569k | 572k |
| Total Equity | 6.03M | 5.69M | 6.1M | 5.54M | 57.83M |
| Year End September 29 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 20.04M | 12.09M | 6.88M | 6.11M |
| Total Liabilities | 639k | 1.54M | 281k | 569k |
| Total Equity | 19.4M | 10.54M | 6.6M | 5.54M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | ||
| Operating | -822k | -1.63M | -1.39M | -1.85M | -1.49M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 878k | 856k | 834k | 810k | 52.04M |
| Year End September 29 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -7.32M | -13.59M | -7.03M | -1.85M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 26.06M | 5.2M | 2.19M | 810k |
| Market Cap | 241.12M |
| Price to Earnings Ratio | -85.78 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 42.02 |
| Price to Book Ratio | 43.42 |
| Dividend Yield | - |
| Shares Outstanding | 6.99M |
| Average Volume (1 week) | 50.35k |
| Average Volume (1 Month) | 55.61k |
| 52 Week Change | 2,125.81% |
| 52 Week High | 79.02 |
| 52 Week Low | 0.93 |
| Spread (Intraday) | 12.06 (28.41%) |
| Company Name | Bright Minds Biosciences Inc |
| Address |
1500 - 1055 west georgia street vancouver, british columbia V6E 4N7 |
| Website | https://www.brightmindsbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
